Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VRTX, INCY, GILD, BIIB, MYL. These five stock positions account for 25.41% of Sectoral Asset Management's total stock portfolio.
- Added to shares of Actavis (+$105.70M), BSX (+$81.83M), GILD (+$81.61M), MDVN (+$46.96M), IMGN (+$43.21M), Amgen (+$33.09M), Aveo Pharmaceuticals (+$25.51M), IRWD (+$14.62M), EW (+$12.88M), ACHN (+$10.25M).
- Started new stock positions in BSX, ACHN, Actavis.
- Reduced shares in these stocks: WPI (-$90.43M), LIFE (-$79.08M), ONXX (-$39.37M), BIIB (-$37.19M), AFFY (-$21.55M), REGN (-$20.18M), UTHR (-$17.64M), ELN (-$15.86M), MYL (-$14.57M), SQNM (-$13.65M).
- Sold out of its positions in AFFY, ELN, HSP, LMNX, OPTR, STJ, WPI.
- As of March 31, 2013, Sectoral Asset Management has $3.25B in assets under management (AUM). Assets under management grew from a total value of $2.86B to $3.25B.
- Independent of market fluctuations, Sectoral Asset Management was a net buyer by $60.54M worth of stocks in the most recent quarter.
Sectoral Asset Management portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 5.90 | +2.00% | 3493219 | 54.97 | 79.49 |
| INCY | Incyte Corporation | 5.62 | 7805288 | 23.41 | 22.30 | |
| GILD | Gilead Sciences | 5.04 | +99.00% | 3347975 | 48.94 | 57.70 |
| BIIB | Biogen Idec | 4.51 | -20.00% | 761116 | 192.62 | 236.91 |
| MYL | Mylan | 4.34 | -9.00% | 4870259 | 28.95 | 31.11 |
| BMRN | BioMarin Pharmaceutical | 4.11 | +2.00% | 2146264 | 62.26 | 67.45 |
| ONXX | Onyx Pharmaceuticals | 4.05 | -23.00% | 1482183 | 88.86 | 92.88 |
| EW | Edwards Lifesciences | 3.91 | +11.00% | 1547933 | 82.16 | 66.51 |
| Actavis | 3.25 | NEW | 1147566 | 92.11 | 0.00 | |
| ILMN | Illumina | 2.93 | -6.00% | 1763689 | 53.98 | 73.60 |
| CELG | Celgene Corporation | 2.89 | -3.00% | 809536 | 115.91 | 127.81 |
| IMGN | ImmunoGen | 2.76 | +92.00% | 5591239 | 16.07 | 16.94 |
| Align Tech | 2.67 | +9.00% | 2586216 | 33.51 | 0.00 | |
| Amgen | 2.63 | +63.00% | 834119 | 102.51 | 0.00 | |
| PRGO | Perrigo Company | 2.59 | 709525 | 118.74 | 118.22 | |
| BSX | Boston Scientific Corporation | 2.52 | NEW | 10477506 | 7.81 | 9.20 |
| MDVN | Medivation | 2.48 | +139.00% | 1724812 | 46.76 | 47.61 |
| LLY | Eli Lilly & Co. | 2.32 | 1329302 | 56.79 | 54.78 | |
| ARIA | Ariad Pharmaceuticals | 2.27 | +2.00% | 4080984 | 18.08 | 18.37 |
| UTHR | United Therapeutics Corporation | 2.22 | -19.00% | 1184676 | 60.87 | 69.17 |
| VAR | Varian Medical Systems | 2.20 | -11.00% | 992636 | 72.00 | 69.30 |
| IRWD | Ironwood Pharmaceuticals | 2.08 | +27.00% | 3706490 | 18.28 | 13.31 |
| MRK | Merck & Co | 1.97 | +2.00% | 1446989 | 44.23 | 45.35 |
| THRX | Theravance | 1.92 | -5.00% | 2645718 | 23.62 | 37.39 |
| HOLX | Hologic | 1.84 | -4.00% | 2643332 | 22.60 | 21.07 |
| HTWR | HeartWare International | 1.62 | 596550 | 88.41 | 96.01 | |
| LIFE | Life Technologies | 1.46 | -62.00% | 732838 | 64.63 | 73.59 |
| VRX | Valeant Pharmaceuticals Int | 1.42 | -15.00% | 617109 | 75.02 | 78.17 |
| D Alexion Pharmaceutic Als Inc C Common Stock 0 | 1.38 | +2.00% | 486408 | 92.14 | 0.00 | |
| ITMN | InterMune | 1.33 | -11.00% | 4782622 | 9.05 | 10.00 |
| REGN | Regeneron Pharmaceuticals | 1.25 | -33.00% | 230666 | 176.40 | 257.57 |
| NXTM | NxStage Medical | 1.22 | +27.00% | 3529655 | 11.28 | 13.43 |
| Aveo Pharmaceuticals | 1.17 | +202.00% | 5183462 | 7.35 | 0.00 | |
| Covidien | 0.96 | 459374 | 67.84 | 0.00 | ||
| PCYC | Pharmacyclics | 0.92 | 371900 | 80.41 | 82.72 | |
| DXCM | Dex | 0.83 | 1619977 | 16.72 | 21.28 | |
| SHPGY | Shire | 0.79 | +2.00% | 280647 | 91.36 | 0.00 |
| SQNM | Sequenom | 0.76 | -35.00% | 5926774 | 4.15 | 4.07 |
| NPSP | NPS Pharmaceuticals | 0.72 | +29.00% | 2306828 | 10.20 | 14.35 |
| THOR | Thoratec Corporation | 0.54 | 470328 | 37.50 | 31.48 | |
| SGEN | Seattle Genetics | 0.48 | 437069 | 35.50 | 35.55 | |
| TEVA | Teva Pharmaceutical Industries | 0.47 | -19.00% | 383449 | 39.68 | 39.99 |
| RDY | Dr. Reddy's Laboratories | 0.44 | -2.00% | 440590 | 32.35 | 36.77 |
| Amarin Corporation | 0.41 | -27.00% | 1807610 | 7.41 | 0.00 | |
| Given Imaging | 0.35 | -40.00% | 699016 | 16.35 | 0.00 | |
| Sagent Pharmaceuticals | 0.35 | -18.00% | 651356 | 17.55 | 0.00 | |
| Akorn | 0.34 | 794682 | 13.83 | 0.00 | ||
| MNTA | Momenta Pharmaceuticals | 0.33 | -10.00% | 805196 | 13.34 | 12.86 |
| SSRX | 3SBio | 0.33 | -22.00% | 713001 | 15.20 | 16.56 |
| ACHN | Achillion Pharmaceuticals | 0.32 | NEW | 1171500 | 8.75 | 7.78 |
| HALO | Halozyme Therapeutics | 0.30 | +93.00% | 1679962 | 5.77 | 7.67 |
| OSUR | OraSure Technologies | 0.26 | +32.00% | 1586028 | 5.40 | 4.41 |
| Accuray | 0.16 | +2.00% | 1125433 | 4.64 | 0.00 | |
| NVO | Novo Nordisk A/S | 0.06 | -25.00% | 11301 | 161.49 | 171.03 |
| NVS | Novartis AG | 0.02 | -2.00% | 8200 | 71.22 | 74.21 |
| CHINA CORD Blood | 0.01 | 78185 | 2.93 | 0.00 |
Past 13F-HR SEC Filings for Sectoral Asset Management
- Sectoral Asset Management 2012 Q4 - filed Feb. 14, 2013
- Sectoral Asset Management 2012 Q3 - filed Nov. 13, 2012
- Sectoral Asset Management 2012 Q2 - filed Aug. 13, 2012
- Sectoral Asset Management 2012 Q1 - filed May 14, 2012
- Sectoral Asset Management 2011 Q4 - filed Feb. 22, 2012
- Sectoral Asset Management 2011 Q3 - filed Nov. 14, 2011
- Sectoral Asset Management 2011 Q2 - filed Aug. 11, 2011
- Sectoral Asset Management 2011 Q1 - filed May 13, 2011
- Sectoral Asset Management 2010 Q4 - filed Feb. 9, 2011